Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Cancers|December 17, 2024
Landscape of Biomarkers and Pathologic Response in Rectal Cancer: Where We Stand?Abrahams Ocanto, Macarena Teja, Francesco Amorelli, et al.Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 17, 2025
Results of radical treatment of locally advanced rectal cancer in geriatric and non-geriatric patientsAbrahams Ocanto, Ramón Cantero, Rosa Morera, et al.Archivos Espanoles De Urologia|August 8, 2025
GnRH Antagonists: Current Evidence and Role in Prostate CancerAntonio Lazo, Manuel Blanco, Abrahams Ocanto, et al.Cancers|July 13, 2024
Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?María Antonia Gómez-Aparicio, Fernando López-Campos, David Buchser, et al.Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 22, 2024
Evolution of dosimetric treatment planning for pediatric total lymphoid irradiation (TLI): a single-institution experienceCarlos Ferrer, Concepción Huertas, Abrahams Ocanto, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 10, 2025
Ultrahypofractionated radiotherapy in one or two sessions for localized prostate cancer: a review of the evidence and future perspectivesMiguel Angel Berenguer-Frances, Abrahams Ocanto, Thomas Zilli, et al.Exploration of Targeted Anti-Tumor Therapy|November 29, 2023
Coronavirus disease 2019 and lung cancer: where are we?Abrahams Ocanto, Xabier Mielgo-Rubio, Javier Luna Tirado, et al.Archivos Espanoles De Urologia|April 7, 2026
Adjuvant Radiotherapy After Cystectomy in Muscle-Invasive Bladder Cancer: Indications, Benefits and Remaining ChallengesPatricia Valencia Nieto, Fernando López-Campos, Patricia Diezhandino García, et al.Cancers|January 23, 2024
MR-LINAC, a New Partner in Radiation Oncology: Current LandscapeAbrahams Ocanto, Lisselott Torres, Miguel Montijano, et al.Cancers|May 11, 2024
Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in SpainDaniela Gonsalves, Abrahams Ocanto, Eduardo Meilan, et al.Pageof 3